A framework for considering the utility of models when facing tough decisions in public health : a guideline for policy-makers
© 2022. The Author(s)..
The COVID-19 pandemic has brought the combined disciplines of public health, infectious disease and policy modelling squarely into the spotlight. Never before have decisions regarding public health measures and their impacts been such a topic of international deliberation, from the level of individuals and communities through to global leaders. Nor have models-developed at rapid pace and often in the absence of complete information-ever been so central to the decision-making process. However, after nearly 3 years of experience with modelling, policy-makers need to be more confident about which models will be most helpful to support them when taking public health decisions, and modellers need to better understand the factors that will lead to successful model adoption and utilization. We present a three-stage framework for achieving these ends.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Health research policy and systems - 20(2022), 1 vom: 08. Okt., Seite 107 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Thompson, Jason [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Decision support |
|---|
| Anmerkungen: |
Date Completed 11.10.2022 Date Revised 11.10.2022 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1186/s12961-022-00902-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM347243975 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM347243975 | ||
| 003 | DE-627 | ||
| 005 | 20231226033357.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12961-022-00902-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1157.xml |
| 035 | |a (DE-627)NLM347243975 | ||
| 035 | |a (NLM)36209122 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Thompson, Jason |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A framework for considering the utility of models when facing tough decisions in public health |b a guideline for policy-makers |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.10.2022 | ||
| 500 | |a Date Revised 11.10.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022. The Author(s). | ||
| 520 | |a The COVID-19 pandemic has brought the combined disciplines of public health, infectious disease and policy modelling squarely into the spotlight. Never before have decisions regarding public health measures and their impacts been such a topic of international deliberation, from the level of individuals and communities through to global leaders. Nor have models-developed at rapid pace and often in the absence of complete information-ever been so central to the decision-making process. However, after nearly 3 years of experience with modelling, policy-makers need to be more confident about which models will be most helpful to support them when taking public health decisions, and modellers need to better understand the factors that will lead to successful model adoption and utilization. We present a three-stage framework for achieving these ends | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Decision support | |
| 650 | 4 | |a Decision-making | |
| 650 | 4 | |a Modelling | |
| 650 | 4 | |a Policy | |
| 650 | 4 | |a Public health | |
| 700 | 1 | |a McClure, Roderick |e verfasserin |4 aut | |
| 700 | 1 | |a Scott, Nick |e verfasserin |4 aut | |
| 700 | 1 | |a Hellard, Margaret |e verfasserin |4 aut | |
| 700 | 1 | |a Abeysuriya, Romesh |e verfasserin |4 aut | |
| 700 | 1 | |a Vidanaarachchi, Rajith |e verfasserin |4 aut | |
| 700 | 1 | |a Thwaites, John |e verfasserin |4 aut | |
| 700 | 1 | |a Lazarus, Jeffrey V |e verfasserin |4 aut | |
| 700 | 1 | |a Lavis, John |e verfasserin |4 aut | |
| 700 | 1 | |a Michie, Susan |e verfasserin |4 aut | |
| 700 | 1 | |a Bullen, Chris |e verfasserin |4 aut | |
| 700 | 1 | |a Prokopenko, Mikhail |e verfasserin |4 aut | |
| 700 | 1 | |a Chang, Sheryl L |e verfasserin |4 aut | |
| 700 | 1 | |a Cliff, Oliver M |e verfasserin |4 aut | |
| 700 | 1 | |a Zachreson, Cameron |e verfasserin |4 aut | |
| 700 | 1 | |a Blakely, Antony |e verfasserin |4 aut | |
| 700 | 1 | |a Wilson, Tim |e verfasserin |4 aut | |
| 700 | 1 | |a Ouakrim, Driss Ait |e verfasserin |4 aut | |
| 700 | 1 | |a Sundararajan, Vijay |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Health research policy and systems |d 2003 |g 20(2022), 1 vom: 08. Okt., Seite 107 |w (DE-627)NLM124198422 |x 1478-4505 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2022 |g number:1 |g day:08 |g month:10 |g pages:107 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12961-022-00902-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2022 |e 1 |b 08 |c 10 |h 107 | ||